Here’s why the Volpara (ASX:VHT) share price is surging 5% higher

The Volpara Health Technologies Ltd (ASX:VHT) share price is storming higher on Tuesday after announcing a new acquisition…
The post Here’s why the Volpara (ASX:VHT) share price is surging 5% higher appeared first on The Motley Fool Australia. –

asx 200 share takeover represented by man drawing illustration of big fish eating little fish

The Volpara Health Technologies Ltd (ASX: VHT) share price has returned from its trading halt and is pushing higher on Tuesday.

In morning trade, the health technology software company’s shares are up 5% to $1.56.

Why is the Volpara share price surging higher?

Investors have been buying Volpara’s shares this morning following the announcement of a new acquisition.

According to the release, the company has acquired CRA Health for US$18 million upfront, with an additional US$4 million payable upon it meeting recurring revenue and staff retention targets over the next 18 months. Post-acquisition, Volpara will have ~NZ$35 million cash.

CRA Health is a breast cancer risk assessment company that was spun out from Massachusetts General Hospital, a Harvard Medical School teaching hospital.

The release explains that CRA Health’s cloud based CRA software is tightly integrated into major electronic health record (EHR) systems. It receives patient information, including breast density, and returns the risk of breast cancer alongside appropriate recommendations.

This includes whether additional imaging or genetics testing is advised and reimbursed according to established guidelines. CRA also has electronic interfaces built with all the major genetics companies.

CRA is a profitable, operating cash-flow-positive software-as-a-service (SaaS) company with low customer acquisition costs due to its relationships with the major EHR companies. It now has annualised recurring revenues (ARR) of over US$4 million (NZ$6.2 million) after experiencing strong growth over the last year despite the COVID-19 pandemic.

Its software covers around 2.4 million women, or approximately 6% of US screenings, with an average revenue per user (ARPU) of approximately US$1.70. Unaudited revenue for its last financial year ended 31 December 2020 was US$3.1 million.

A very significant acquisition

Volpara’s CEO, Dr Ralph Highnam, believes the acquisition of CRA is significant.

He said: “The acquisition of CRA is very significant for Volpara. CRA is a leading provider of risk assessment tools within major EHR systems and has integrations already built with the main genetics companies. CRA has a strong science background, just like Volpara, and provides us with world-class knowledge about risk and genetics. CRA is expected to benefit the Volpara brand and will accelerate us on our mission to save families from cancer by preventing advanced-stage breast cancer.”

The acquisition will increase group ARR to ~US$17.5 million (NZ$26.9 million) and group ARPU to over US$1.40.

Volpara’s Chair, Paul Reid, added: “We have known CRA for a long time, and they share our values, mission, and scientific background. We can’t wait to see the results of combining these two global leaders and the positive effect these will have on women’s healthcare.”

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends VOLPARA FPO NZ. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Here’s why the Volpara (ASX:VHT) share price is surging 5% higher appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!